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ABSTRACT
This study determined the effect of the adenovirus E1A gene on nitric oxide (NO) production in alveolar
epithelial (A549) cells. E1A-positive A549 cells (E1A transfectants), E1A-negative A549 cells (control
transfectants) and untransfected A549 cells were placed in 96-well tissue culture plates. After
stimulation with lipopolysaccharide (LPS) or cytokine mixture (CM), the biochemical reaction products
of NO (nitrite and nitrate) in the culture medium were measured by chemiluminescence. The inducible
(iNOS) and the endothelial (eNOS) isoforms of nitric oxide synthase (NOS) protein expression were
examined by Western blotting. iNOS mRNA expression was examined by Northern blotting and
RT-PCR. CM-induced NO production by E1A-positive A549 cells was significantly lower than that of
E1A-negative cells (p < 0.0001). LPS stimulation failed to enhance NO production in both cell types. CM
induced iNOS protein expression in E1A-negative A549 cells, but not in E1A-positive cells. eNOS
protein expression was constitutive and was not affected by CM stimulation, LPS stimulation or E1A.
CM induced iNOS mRNA expression in E1A-negative A549 cells, but not in E1A-positive cells. In
conclusion, the adenovirus E1A gene suppressed NO production through transcriptional control of the
iNOS gene in A549 cells. This inhibition of NO production may enable the virus to persist in human
tissue, since NO is an antiviral effector of the innate immune system.
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INTRODUCTION
Adenoviruses are a group of DNA viruses that
infect the epithelial cells of the respiratory, gas-
trointestinal and genitourinary tracts. Infection is
usually self-limiting, but latent virus infection is
implicated as a risk-factor for obstructive lung
diseases [1,2]. Adenovirus has been detected at
high frequency in children with steroid-resistant
asthma [2]. Adenovirus E1A protein and mRNA
are detected frequently in the lungs of patients
with chronic obstructive pulmonary disease
(COPD) [1,3]. Studies of cultured human alveolar
epithelial cells have also shown that transfection
with this virus gene upregulates the expression of
intercellular adhesion molecule-1 (ICAM-1) and
interleukin-8 when these cells are challenged with
endotoxin or noxious particles [4–7]. These stud-
ies suggest that latent adenovirus infections, and
the persistence of the E1A gene in the alveolar
epithelial cells, may have a role in the pathogen-
esis of obstructive airway disease by amplifying
the inflammation [8].
Nitric oxide (NO) is an antiviral effector of the
innate immune system, and inhibits replication of
a wide variety of DNA and RNA viruses in cell
cultures and animals. Cao et al. [9] showed that
adenovirus E1A suppressed inducible NO syn-
thase (iNOS) expression in the mouse macroph-
age cell line RAW264.7. Viral inhibition of NO
may affect the host innate immune system and
enable viruses to survive in the lung. Therefore,
the aim of this study was to determine whether
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NO production by human alveolar epithelial cells
is affected by the adenovirus E1A gene. The effect
of E1A on iNOS and endothelial NO synthase
(eNOS) expression in these cells was also studied.
MATERIALS AND METHODS
Reagents
Lipopolysaccharide (LPS) from Escherichia coli strain 0111:B4
(Sigma, St Louis, MO, USA) was dissolved in sterile distilled
water. The final concentration of LPS was 10 lg ⁄L. Recombin-
ant human tumour necrosis factor-a, interferon-c (IFN-c) and
interleukin-1b were purchased from Roche Diagnostics (Basel,
Switzerland) and were used to produce a cytokine mixture
(CM: tumour necrosis factor-a 10 ng ⁄mL; interleukin-1b
500 U ⁄mL; IFN-c 100 U ⁄mL).
Cell culture
The cells used in this study have been described previously
[4,5,10]. In brief, A549 cells (ATCC, Rockville, MD, USA)
were transfected with the E1A gene of adenovirus 5. The
E1A transfectants E4 and E11 investigated in this study were
A549 cell clones that were transfected stably with a plasmid
carrying the adenovirus 5 E1A gene, driven by its own
promoter, while control transfectants C4 and C8 were clones
transfected with a control plasmid lacking the E1A gene.
Analysis by Western and Northern blots showed that all E1A
transfectants produced relatively high levels of E1A mRNA
and proteins [4]. Wild-type and transfected A549 cells were
grown in Eagle’s minimum essential medium supplemented
with fetal bovine serum 10% v ⁄v (Hyclone, Logan, UT,
USA). Transfectants were maintained under constant selec-
tion with active G418 (Gibco BRL, Rockville, MD, USA)
280 mg ⁄L.
Measurements of nitrite and nitrate
To measure NO production by A549 cells, the biochemical
reaction products of NO (nitrite and nitrate) were measured
in the culture medium. Cells were placed in 96-well tissue
culture plates at 4 · 104 cells ⁄well on the day before stimu-
lation with LPS or CM. The culture medium was collected
after incubation for 24 h with or without stimulation. The
nitrate (NO3
–) in culture medium was reduced to nitrite
(NO2
–) with Aspergillus nitrate reductase (DOJINDO, Kuma-
moto, Japan). The resulting nitrite content of the incubation
medium was measured by a chemiluminescence technique
involving a glass purge–reflux vessel connected to an NO
analyser (NOA 280; Sievers Instruments, Boulder, CO, USA).
Aliquots (10 lL) of the culture medium that had been treated
with the converting enzyme were injected into the purge–
reflux vessel, where nitrite was reduced to NO by potassium
iodide 1% v ⁄v in glacial acetic acid. NO was then detected by
the NO analyser.
Western blot analysis
Cells were lysed with the Mammalian Cell Lysis Kit (Sigma).
The protein concentration was measured by the Bio-Rad
protein assay (Bio-Rad, Hercules, CA, USA). Protein (30 lg)
from A549 cells was separated by electrophoresis through
SDS-PAGE 10% w ⁄v gels and transferred to nitrocellulose
(Hybond-ECL; Amersham, Arlington Heights, IL, USA).
Membranes were blocked with Tris-buffered saline containing
skimmed milk 5% w ⁄v and Tween-20 0.1% w ⁄v, and then
incubated with the primary antibodies, anti-iNOS (1:100; Santa
Cruz Biotechnology, Santa Cruz, CA, USA), anti-eNOS (1:100;
Santa Cruz Biotechnology), anti-ICAM-1 (1:200; Santa Cruz
Biotechnology), anti-b-actin (1:1000; Sigma), anti-adenovirus
5 E1A (1:2000; Sigma) in Tris-buffered saline containing
skimmed milk 5% w ⁄v and Tween-20 0.1% w ⁄v at room
temperature for 1 h. The blots were washed extensively and
then incubated for 1 h with anti-rabbit IgG conjugated to
horseradish peroxidase (1:25 000; Amersham) or anti-mouse
IgG conjugated to horseradish peroxidase (1:50 000; Amer-
sham). Binding of secondary antibody was detected using an
enhanced chemiluminescence detection system (ECL plus;
Amersham).
iNOS mRNA expression
iNOS mRNA expression was examined by Northern blotting
and RT-PCR. Northern blotting was performed as described
previously [11]. A549 cells, grown until they were confluent in
10-cm dishes, were left in media or exposed to LPS 10 lg ⁄L or
CM for 6 h, after which total RNA was extracted with Isogen
(Wako, Osaka, Japan). This RNA, at 20 lg ⁄ lane, was separated
on a formaldehyde–agarose 1% w ⁄v gel, transferred to a
Hybond-N membrane (Amersham) and fixed to the mem-
brane under vacuum at 80C. Next, the membrane was
prehybridised, and then hybridised for 20 h with the DNA
probes, which were labelled with [a-32P]-dCTP (Amersham)
using random primers. RT-PCR was performed as described
previously [12]. Total RNA (1 lg) was reverse transcribed to
cDNA using a Takara RNA-PCR kit (Takara, Kyoto, Japan)
according to the manufacturer’s recommendations. Briefly,
total RNA, random hexadeoxyribonucleotides and avian
myeloblastosis virus reverse transcriptase were used for
cDNA synthesis. The cDNA was amplified by PCR, using
specific primers for iNOS (5¢-CAAGTGGAAGTTCACCAA-
CAGC-3¢ and 5¢-GATATCTTCGTGATAGCGCTTCTGGC-3¢
[13,14]) and a control mRNA, GAPDH (5¢-ATTCCATGGC-
ACCGTCAAGGCT-3¢ and 5¢-TCAGGTCCACTGACACGT-3¢).
Amplification was performed with cycles of 95C for 1 min,
55C for 30 s and 72C for 1 min in a thermal cycler (Perkin-
Elmer ⁄Applied BioSystems, Foster City, CA, USA). In prelim-
inary experiments, the appropriate PCR cycle number was
selected from cycle numbers that showed a linear relationship
to the signal intensity from the PCR product on ethidium
bromide-stained agarose gels. For semiquantitative evaluation
of iNOS and GAPDH mRNAs, 30 and 26 cycles were chosen,
respectively. The PCR products were analysed on an agarose
1% w ⁄v gel, and the intensity of the ethidium bromide
fluorescence was evaluated by NIH Image v. 1.62 (National
Institutes of Health, Bethesda, MD, USA).
Statistical analysis
Data were expressed as a group mean ± SEM, with n referring
to the number of wells studied in each group. Group
comparisons were made through an analysis of variance
(ANOVA) with Bonferroni’s correction for multiple comparisons.
Values of p < 0.05 were considered significant.
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RESULTS
NO production by A549 cells
To determine NO production by A549 cells, nitrite
and nitrate were measured in the culture super-
natant. In the absence of any stimulation, NO
production by A549 cells was not affected by the
adenovirus E1A gene (Fig. 1). NO production by
A549 cells and E1A-negative cells (control trans-
fectants) was enhanced after stimulation for 24 h
with CM, but not after stimulation with LPS. In
contrast, NO production by E1A-positive cells
was not enhanced after stimulation with either
CM or LPS. In the E1A-positive cells (E4), NO
production induced by CM was significantly
lower than that in the untransfected A549 cells
and E1A-negative cells (C8) (untransfected A549
cells, 11.93 ± 0.29 lM; E1A-negative cells, 10.33 ±
0.19 lM; E1A-positive cells, 7.39 ± 0.26 lM;
p < 0.0001). Similar results were obtained for
the second set of E1A-negative and -positive
transfected clones (C4 and E11, respectively) (data
not shown).
Western blot analysis of iNOS and eNOS
protein expression
To determine which isoform of NOS was sup-
pressed by the E1A gene, iNOS and eNOS
proteins were examined by Western blotting.
iNOS protein expression was not detected, or
was barely detectable, without stimulation,
regardless of the presence of E1A (Fig. 2). CM
stimulation induced iNOS protein expression in
untransfected A549 cells and E1A-negative trans-
fectants (C8); however, CM did not induce iNOS
protein expression in E1A-positive transfectants
(E4). LPS stimulation did not enhance production
of the iNOS protein in either cell type, while LPS
induced ICAM-1 protein expression in both cells.
LPS-induced ICAM-1 expression was stronger in
E1A-positive cells than in E1A-negative cells.
eNOS protein expression was constitutive, and
was not affected by either E1A or CM stimulation.
Similar results were obtained for the second set of
E1A-negative and -positive transfected clones (C4
and E11, respectively) (data not shown).
iNOS mRNA expression
In the absence of stimulation, iNOS mRNA
expression was not detected, regardless of the
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Fig. 1. Nitric oxide (NO) (nitrite and nitrate) concentration
in the culture medium of A549 cells, after stimulation with
lipopolysaccharide or cytokine mixture for 24 h. Data are
expressed as the mean ± SEM of ten experiments. NS, no
stimulation; LPS, stimulation with lipopolysaccharide
10 mg ⁄L; CM, stimulation with cytokine mixture (tumour
necrosis factor-a 10 ng ⁄mL, interleukin-1b 500 U ⁄mL, and
interferon-c 100 U ⁄mL). *p < 0.0001 compared to A549
cells and E1A-negative transfectants.
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Fig. 2. Western blot analysis of inducible nitric oxide
synthase, endothelial nitric oxide synthase, adenovirus
E1A and intercellular adhesion molecule-1 (ICAM-1) pro-
tein expression. EIA(–), adenovirus E1A-negative transfect-
ant; E1A(+), adenovirus E1A-positive transfectant; NS, no
stimulation; LPS, stimulation with lipopolysacharide; CM,
stimulationwith cytokinemixture (tumour necrosis factor-a
10 ng ⁄mL, interleukin-1b 500 U ⁄mL, and interferon-c
100 U ⁄mL); iNOS, inducible isoform of nitric oxide syn-
thase; eNOS, endothelial isoform of nitric oxide synthase.
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presence of E1A (Fig. 3A). LPS stimulation did
not induce iNOS mRNA expression. CM induced
iNOS mRNA expression in untransfected A549
cells and the E1A-negative transfectants (C8), but
not in the E1A-positive transfectants (E4). To
confirm the results from Northern blotting,
RT-PCR of iNOS mRNA was performed for two
different pairs of transfected A549 cells (Fig. 3B).
In the absence of stimulation, iNOS mRNA
expression was not detected in A549 cells or in
the E1A-negative transfectant C8 and the E1A-
positive transfectant E4 of the first pair. Individ-
ual stimulation with each cytokine (IFN-c, tumour
necrosis factor-a or interleukin-1b), LPS, or the
iNOS
GAPDH
A549 cells E1A(-) E1A (+)
NS LPS CM
28S
18S
18S
NS LPS CM NS LPS CM
A549
E1A(-)
E1A(+)
iNOS
GAPDH
iNOS
GAPDH
iNOS
GAPDH
NS
 
CM LP
S
IF
N-
γ
TN
F-α
LP
S+
IFN
-γ
IL
-1
iN
O
S 
/ G
A
PD
H
 ra
tio
Stimulation
0
20
40
60
80
100
120
140
160
NS CM IFN TNF IL-1 LPS LPS+IFN
*
**
A549 cells
E1A-negative 
transfectant
E1A-positive 
transfectant
(a)
(b)
(c)
Fig. 3. Inducible nitric oxide synthase mRNA expression in A549 cells. (A) Northern blot analysis. EIA(–), adenovirus
E1A-negative transfectant; E1A(+), adenovirus E1A-positive transfectant; NS, no stimulation; LPS, stimulation with
lipopolysaccharide; CM, stimulation with cytokine mixture (tumour necrosis factor-a 10 ng ⁄mL, interleukin-1b 500 U ⁄mL,
and interferon-c 100 U ⁄mL); iNOS, inducible isoform of nitric oxide synthase. (B) Inducible nitric oxide synthase and
GAPDH RT-PCR; a representative ethidium bromide-stained agarose gel of the RT-PCR products. iNOS, inducible isoform
of nitric oxide synthase; EIA(–), adenovirus E1A-negative transfectant; E1A(+), adenovirus E1A-positive transfectant; NS,
no stimulation; CM, stimulation with cytokine mixture (tumour necrosis factor-a 10 ng ⁄mL, interleukin-1b 500 U ⁄mL, and
interferon-c 100 U ⁄mL); IFN-c, stimulation with interferon-c; TNF-a, stimulation with tumour necrosis factor-a; IL-1,
stimulation with interleukin-1; LPS, stimulation with lipopolysaccharide; LPS+IFN-c, stimulation with lipopolysaccharide
and interferon-c. (C) Densitometric analysis of the RT-PCR products from (A). The density of the inducible nitric oxide
synthase (iNOS) RT-PCR product was corrected by that of the corresponding GAPDH band. Data are shown as the
mean ± SEM of four experiments. NS, no stimulation; CM, stimulation with cytokine mixture (tumour necrosis factor-a
10 ng ⁄mL, interleukin-1b 500 U ⁄mL, and interferon-c 100 U ⁄mL); IFN-c, stimulation with interferon-c; TNF-a, stimulation
with tumour necrosis factor-a; IL-1, stimulation with interleukin-1; LPS, stimulation with lipopolysaccharide; LPS+IFN-c,
stimulation with lipopolysaccharide and interferon-c. *p < 0.001, **p < 0.0001 compared to A549 cells and the E1A-
negative transfectant.
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combination of LPS and IFN-c, did not induce
iNOS mRNA in either set of cells. CM induced
iNOS mRNA expression in A549 cells and the
E1A-negative transfectant, but not in the E1A-
positive transfectant.
Densitometric analysis of the ethidium bro-
mide-stained bands, representing the iNOS and
GAPDH mRNA RT-PCR products, confirmed
that expression of the iNOS mRNA was signifi-
cantly lower in the E1A-positive transfectants
than in A549 cells and the E1A-negative trans-
fectants (Fig. 3C; n = 4, p < 0.0001). Similar
results were obtained for the second set of E1A-
negative and -positive transfected clones (C4 and
E11, respectively) (data not shown).
DISCUSSION
The adenovirus E1A gene inhibited NO produc-
tion by blocking expression of iNOS in human
alveolar epithelial cells. These results are consis-
tent with a report showing that E1A suppressed
iNOS expression in a mouse macrophage cell line
[9]. In the present study, E1A suppressed not only
iNOS expression, but also total NO production, in
human alveolar epithelial cells. NO is an antiviral
effector of the innate immune system [15]. Viral
inhibition of NO production by alveolar cells may
result in the repression of the innate immune
system in the lung, and may enable viruses to
persist in the lung. Studies with a guinea-pig
model of human adenovirus 5 infection have
shown that deposition of the virus in the nasal
cavity is followed by virus replication in the lung
and persistence of the virus E1A gene, with
expression of its protein, in lung epithelial cells
long after virus replication stops [16]. Studies
suggest that latent adenovirus infection is one of
the factors that can amplify lung inflammation
[1,3,8]. The adenovirus targets lung epithelium,
and its DNA persists in large quantities in the
lungs of patients with COPD, while E1A proteins,
which act as adenovirus transactivators, have
been demonstrated in the epithelium of the
conducting airways, bronchial glands and alveo-
lar epithelium [16,17]. Retamales et al. [3] repor-
ted a 40-fold increase in the number of alveolar
epithelial cells expressing adenovirus E1A protein
in the lungs of patients with severe COPD,
compared to patients without COPD. Previous
studies showed enhanced expression of ICAM-1
and interleukin-8 mRNA in A549 cells expressing
E1A protein [4,5,7,11]. These data support the
hypothesis that adenovirus E1A protein amplifies
inflammation in the lung and participates in the
destruction of the lung.
The suppressive effect of E1A on NO produc-
tion may appear to contradict the results of previ-
ous studies that showed the inflammatory
enhancement effect of E1A [1–6], because NO
has been convincingly identified as a pro-inflam-
matory mediator [18]. However, it should be
emphasised that NO also has an anti-inflamma-
tory effect in some conditions [19,20]. NO has a
biphasic effect on nuclear factor kappa B binding
activity and regulation of the transcription of
inflammatory mediators [19]. The effect of NO is
likely to depend on the local concentration of NO,
and enables it to both upregulate and downregu-
late the expression of host defence proteins [19].
NO also has anti-apoptotic activity, and thus a
protective role in the LPS-induced acute lung
injury model [21]. Therefore, suppression of NO
by E1A may result in disruption of this complex
regulating system of inflammation in the lung.
Previous studies have shown that E1A enhan-
ces the expression of ICAM-1 and interleukin-8
induced by LPS in A549 cells [4,5]. However, in
the present study, LPS had no effect on NO
production or iNOS protein expression in A549
cells, regardless of the presence of E1A, while it
induced ICAM-1 expression, with stronger
expression in E1A-positive cells. These results
also showed that the LPS used in this study was
biologically active, although it did not induce
NO in A549 cells. CM induced iNOS mRNA and
protein, but there was no induction with LPS or
any individual cytokine in A549 cells. This result
is consistent with previous reports showing that
iNOS mRNA was induced by CM, or culture
supernatants of monocytes stimulated with LPS,
but not by individual cytokines or LPS alone
[22].
E1A proteins localise in the nuclei of target
cells, where they interact with a variety of cellular
transcription factors that regulate the expression
of certain cellular genes. In this manner, E1A
could affect transcription factors which, in
response to CM stimulation, bind to the promo-
ter–enhancer regions of inflammatory genes. Cao
et al. [9] showed that E1A suppressed iNOS
expression by inhibiting the nuclear factor kappa
B transcription factor. Nuclear factor kappa B is
clearly important in the induction of murine
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iNOS, but appears to be less important in the
regulation of the human gene [23–25]. Human
iNOS regulation appears to require IFN-c and the
activation of the transcription factor signal trans-
ducers and activators of transcription (STAT)-1
[24,26]. Adenovirus E1A suppresses the activation
of STAT-1 [27,28]. Therefore, the inhibitory effect
of E1A on iNOS mRNA expression could be
attributed to a block of the STAT-1 pathway
required for the IFN-c response.
In conclusion, the adenovirus E1A gene sup-
pressed NO production through transcriptional
control of the iNOS gene in A549 cells. This
inhibition of NO production may enable the virus
to persist in human tissue, since NO is an antiviral
effector of the innate immune system.
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